Navigation Links
Herbruck Alder to Convene Summit: 'Coming Together to Explain Healthcare Legislation'
Date:8/11/2009

CLEVELAND, Aug. 11 /PRNewswire/ -- Herbruck Alder, a Cleveland-based employee benefits firm, will convene six medical insurance companies on Thursday, August 20 at LaCentre Conference Center in Westlake to explain the impact of pending federal healthcare legislation on employers.

"This conference is extraordinarily important because Americans across the country are discussing and debating the Obama administration's proposed healthcare changes," said Mark Alder president of Herbruck Alder. "We are delighted that these competing firms are coming together to bring Greater Cleveland employers their knowledge, position, and expertise on this timely and complicated subject."

Grace-Marie Turner, president of the Galen Institute, a non-profit research organization focused on health policy, will present the keynote address. Turner, who speaks extensively about promoting a more competitive, patient-centered healthcare marketplace, has been published in The Wall Street Journal and USA Today and is frequently interviewed on radio and television.

The participating companies are Aetna, Anthem Blue Cross and Blue Shield, Cigna, Kaiser Permanente, Medical Mutual of Ohio, and UnitedHealthcare.

The conference, which is by invitation to human resources and other decision-making executives, will take place from 8 a.m. to 1:30 p.m.

LaCentre is on Detroit Road near the I-90 interchange at Columbia Road. For reservations please contact Alison Muth at 216.623.2600 or go to www.herbruckalder.com.


'/>"/>
SOURCE Herbruck Alder
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
2. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
3. Tasker Products Rolls Out Scalder Application at Two New Poultry Processors Facilities
4. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
5. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
6. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
7. Galderma Completes Tender Offer for CollaGenex
8. Galderma announces approval for Differin gel 0.1 percent in Japan
9. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
10. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
11. Galderma Launches New Cetaphil(R) SPF 50 Product
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 2Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 3Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference 2Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies 61577 1Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies 61577 2Doctors Research Group Receives FDA Clearance for U S Distribution of KRYPTONITE 28TM 29 Bone Cement 14882 1Doctors Research Group Receives FDA Clearance for U S Distribution of KRYPTONITE 28TM 29 Bone Cement 14882 2Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 1Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 2Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 3Quest Diagnostics Announces Pricing of Tender Offer for Any and All of Certain of its Outstanding Notes 6360 4